Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28590069 | 0.93 | CYP3A4 (0.37) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL3924212 | 0.85 | LMNA (0.50) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL3924209 | 0.85 | LMNA (0.50) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL7149173 | 0.83 | IDO1 (0.43) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL30988801 | 0.82 | GABRA1 (0.42) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL29256514 | 0.82 | GABRA1 (0.42) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL29256516 | 0.82 | GABRA1 (0.42) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL11602112 | 0.82 | CYP3A4 (0.51) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL3929701 | 0.82 | CYP2D6 (0.42) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 | |
| SCHEMBL6055228 | 0.82 | TAS1R3 (0.42) | GABRA1GABRB2CYP3A4CYP2D6SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018115-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | LOXO ONCOLOGY, INC. | 2024-01-18 | — | — | US | disclosed |
| EP-3906969-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | East China University of Science and Technology (CN) | 2021-11-10 | — | — | EP | disclosed |
| WO-2020249117-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | 华东理工大学 | 2020-12-17 | — | — | WO | disclosed |
| EP-1506239-A2 | SURFACE GRAFT MODIFIED RESINS AND FORMATION THEREOF | Phenomenex, Inc. (US) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003064478-A2 | SURFACE GRAFT MODIFIED RESINS AND FORMATION THEREOF | PHENOMENEX, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018115-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | PIK3CA, PIK3R4, PIK3R5 | GABRA1 2549/4885GABRB2 2997/4885CYP3A4 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.